CCM Cure Roadmap
New CCM Cure Roadmap shows the way to a cure We have a new resource showing the overlapping steps we are taking to achieve a permanent cure for CCM. We are grateful to the Chan…
Patient Participation
CCM 101
CCM 101 is an informational meeting for new members offered on the first Thursday of the month, at 7:00 PM Eastern. We’ll review slides covering the basics of the illness…
Recursion’s REC-994 Trial Fully Enrolled
We are thrilled to announce that the Phase 2 safety trial of Recursion’s REC-994 medicine, being developed specifically for symptomatic CCM, has fully enrolled 60 patients ahead of schedule. Our…
Learn More About Clinical Trials
Learn more about how clinical trials work, check out some Myths vs Facts and get your questions answered with our FAQs. Still have more questions? Reach out at ClinicalTrials@AllianceToCure.org
Atorvastatin Trial Has Completed Enrollment
August 1, 2022 – The atorvastatin experimental proof of concept trial to treat cavernous malformations with symptomatic hemorrhage, hosted at the University of Chicago, has completed enrollment. We congratulate and…
